Arbor Pharmaceuticals Email Format

Pharmaceutical ManufacturingGeorgia, United States51-200 Employees

Arbor Pharmaceuticals is a U.S.-based specialty pharmaceutical company active in the pharmaceutical manufacturing sector. Based in Atlanta, Georgia, the firm has developed and brought to market medicines such as Nymalize, a nimodipine oral solution, and Cetylev, an acetylcysteine effervescent tablet. The company has pursued U.S. collaborations, including a 2018 agreement with Tasly Pharmaceutical Group to advance R&D and marketing of T89 in the United States. In 2021 Arbor Pharmaceuticals was acquired by Azurity Pharmaceuticals, integrating its operations into Azurity's platform. The organization maintains a mid-sized footprint with a dedicated focus on delivering specialty medicines to the U.S. healthcare system.

Sign up for free to view info

Company overview Employee directory